Beam Therapeutics

About:

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Website: https://beamtx.com

Twitter/X: beamtx

Top Investors: F-Prime Capital, ARCH Venture Partners, Perceptive Advisors, Cormorant Asset Management, Google Ventures

Description:

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the dna.